Patent Assignment
Reel/Frame 071491/0251
Change of Name
Recorded: 2025-06-02
Pages: 3
Assignor
CREALTA PHARMACEUTICALS LLC
Executed: 2016-01-13
Assignee
HORIZON PHARMA USA RHEUMATOLOGY LLC
150 S. SAUNDERS RD., LAKE FOREST, ILLINOIS, 60045
Covered Property
(1)
Methods and Kits for Predicting Infusion Reaction Risk and Antibody Mediated Loss of Response by Monitoring Serum Uric Acid During Pegylated Uricase Therapy
Application:
18/961,687 →
Publication:
US 2025/0231181
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 2, 2025
From: ROSARIO-JANSEN, THERESA; WRIGHT, DAVID ERICK
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 071282/0482 →
Assignment of Assignor's Interest
Jun 2, 2025
From: SAVIENT PHARMACEUTICALS, INC.; SAVIENT PHARMA HOLDINGS, INC.
To: CREALTA PHARMACEUTICALS LLC
Reel/Frame 071467/0541 →
Assignment of Assignor's Interest
Jun 2, 2025
From: HORIZON PHARMA RHEUMATOLOGY LLC
To: HORIZON THERAPEUTICS USA, INC.
Reel/Frame 071491/0279 →
Change of Name
Jun 2, 2025
From: HORIZON PHARMA USA RHEUMATOLOGY LLC
To: HORIZON PHARMA RHEUMATOLOGY LLC
Reel/Frame 071491/0482 →